Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey.

[1]  R. Winer,et al.  Natural History of HPV Infection across the Lifespan: Role of Viral Latency , 2017, Viruses.

[2]  P. Gravitt,et al.  Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution , 2017, The Journal of infectious diseases.

[3]  B. Akgül,et al.  Molecular Mechanisms of Human Papillomavirus Induced Skin Carcinogenesis , 2017, Viruses.

[4]  Qiang Sun,et al.  The Papillomavirus Episteme: a major update to the papillomavirus sequence database , 2016, Nucleic Acids Res..

[5]  A. Giuliano,et al.  Seroprevalence of cutaneous human papillomaviruses (HPVs) among men in the multinational HPV Infection in Men study. , 2016, The Journal of general virology.

[6]  A. Giuliano,et al.  Seroprevalence and Associated Factors of 9-Valent Human Papillomavirus (HPV) Types among Men in the Multinational HIM Study , 2016, PloS one.

[7]  E. Unger,et al.  Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006. , 2016, The Journal of infectious diseases.

[8]  M. Eisenberg,et al.  Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003–2012 , 2015, BMC Infectious Diseases.

[9]  A. Giuliano,et al.  Seroconversion following anal and genital HPV infection in men: The HIM study , 2015, Papillomavirus research.

[10]  C. Bonvicino,et al.  Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany , 2015, Virchows Archiv.

[11]  M. Schiffman,et al.  Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. , 2014, The Journal of infectious diseases.

[12]  E. Unger,et al.  Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003–2006 , 2014, Sexually Transmitted Infections.

[13]  D. Lowy,et al.  Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus , 2014, BMC Infectious Diseases.

[14]  A. Kaufmann,et al.  Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling , 2014, BMC Infectious Diseases.

[15]  T. Iftner,et al.  Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany , 2013, BMC Infectious Diseases.

[16]  A. Kaufmann,et al.  Risk Factors for Cervical Human Papillomavirus Infection and High-Grade Intraepithelial Lesion in Women Aged 20 to 31 Years in Germany , 2013, International Journal of Gynecologic Cancer.

[17]  A. Burke,et al.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. , 2013, The Journal of infectious diseases.

[18]  F. Gimenes,et al.  A review of methods for detect human Papillomavirus infection , 2012, Virology Journal.

[19]  H. D. de Melker,et al.  Seroprevalence of seven high-risk HPV types in The Netherlands. , 2012, Vaccine.

[20]  Gert B. M. Mensink,et al.  German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave , 2012, BMC Public Health.

[21]  A. Giuliano,et al.  Seroprevalence of Human Papillomavirus (HPV) Type 6 and 16 Vary by Anatomic Site of HPV Infection in Men , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[22]  A. Antonsson.  Review: Antibodies to cutaneous human papillomaviruses , 2012, Journal of medical virology.

[23]  Jennifer S. Smith,et al.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review. , 2012, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[24]  D. Galloway,et al.  Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. , 2011, The Journal of infectious diseases.

[25]  A. Nardone,et al.  Prevalence of Human Papillomavirus Antibodies in Males and Females in England , 2011, Sexually transmitted diseases.

[26]  William Fulp,et al.  Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study , 2011, The Lancet.

[27]  L. Bruni,et al.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. , 2010, The Journal of infectious diseases.

[28]  W. Quint,et al.  Prevalence of low‐risk and high‐risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study , 2010, Journal of medical virology.

[29]  H. Trottier,et al.  Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. , 2010, Cancer research.

[30]  P. Coursaget,et al.  Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[31]  E. Unger,et al.  Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. , 2009, The Journal of infectious diseases.

[32]  A. Burke,et al.  Correlates of cervicovaginal human papillomavirus detection in perimenopausal women. , 2009, Journal of women's health.

[33]  M. Schiffman,et al.  Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline , 2009, Infectious Agents and Cancer.

[34]  C. Macintyre,et al.  Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  M. Pawlita,et al.  Seroprevalence of 34 Human Papillomavirus Types in the German General Population , 2008, PLoS pathogens.

[36]  E. Unger,et al.  Seroepidemiology of Human Papillomavirus Type 11 in the United States: Results From the Third National Health and Nutrition Examination Survey, 1991–1994 , 2008, Sexually transmitted diseases.

[37]  Jose Jeronimo,et al.  Human papillomavirus and cervical cancer , 2007, The Lancet.

[38]  S. Franceschi,et al.  Serologic Response to Oncogenic Human Papillomavirus Types in Male and Female University Students in Busan, South Korea , 2007, Cancer Epidemiology Biomarkers & Prevention.

[39]  N. Muñoz,et al.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.

[40]  A. Giuliano,et al.  Prevalence of HPV infection among men: A systematic review of the literature. , 2006, The Journal of infectious diseases.

[41]  C. Wheeler,et al.  Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.

[42]  Helen Trottier,et al.  The epidemiology of genital human papillomavirus infection. , 2006, Vaccine.

[43]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[44]  S. Wacholder,et al.  A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.

[45]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[46]  M. Sherman,et al.  Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica , 2003, British Journal of Cancer.

[47]  B. Hansson,et al.  The Ubiquity and Impressive Genomic Diversity of Human Skin Papillomaviruses Suggest a Commensalic Nature of These Viruses , 2000, Journal of Virology.

[48]  N. Kiviat,et al.  Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. , 2000, The Journal of infectious diseases.

[49]  W. Thefeld,et al.  [The German Health Survey. 1997/98]. , 1998, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).